BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 35098692)

  • 1. Cathepsin K activity controls cachexia-induced muscle atrophy via the modulation of IRS1 ubiquitination.
    Meng X; Huang Z; Inoue A; Wang H; Wan Y; Yue X; Xu S; Jin X; Shi GP; Kuzuya M; Cheng XW
    J Cachexia Sarcopenia Muscle; 2022 Apr; 13(2):1197-1209. PubMed ID: 35098692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. REDD1 deletion attenuates cancer cachexia in mice.
    Hain BA; Xu H; VanCleave AM; Gordon BS; Kimball SR; Waning DL
    J Appl Physiol (1985); 2021 Dec; 131(6):1718-1730. PubMed ID: 34672766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.
    Brown JL; Rosa-Caldwell ME; Lee DE; Blackwell TA; Brown LA; Perry RA; Haynie WS; Hardee JP; Carson JA; Wiggs MP; Washington TA; Greene NP
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):926-938. PubMed ID: 28845591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wasting.
    Zhang G; Jin B; Li YP
    EMBO J; 2011 Aug; 30(20):4323-35. PubMed ID: 21847090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia.
    Pin F; Barreto R; Kitase Y; Mitra S; Erne CE; Novinger LJ; Zimmers TA; Couch ME; Bonewald LF; Bonetto A
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):685-700. PubMed ID: 30009406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cryptotanshinone prevents muscle wasting in CT26-induced cancer cachexia through inhibiting STAT3 signaling pathway.
    Chen L; Yang Q; Zhang H; Wan L; Xin B; Cao Y; Zhang J; Guo C
    J Ethnopharmacol; 2020 Oct; 260():113066. PubMed ID: 32505837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine monophosphate-activated protein kinase is elevated in human cachectic muscle and prevents cancer-induced metabolic dysfunction in mice.
    Raun SH; Ali MS; Han X; Henríquez-Olguín C; Pham TCP; Meneses-Valdés R; Knudsen JR; Willemsen ACH; Larsen S; Jensen TE; Langen R; Sylow L
    J Cachexia Sarcopenia Muscle; 2023 Aug; 14(4):1631-1647. PubMed ID: 37194385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity worsens mitochondrial quality control and does not protect against skeletal muscle wasting in murine cancer cachexia.
    Cardaci TD; VanderVeen BN; Bullard BM; McDonald SJ; Unger CA; Enos RT; Fan D; Velázquez KT; Frizzell N; Spangenburg EE; Murphy EA
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):124-137. PubMed ID: 38062911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17A contributes to skeletal muscle atrophy in lung cancer-induced cachexia via JAK2/STAT3 pathway.
    Ying L; Yao Y; Lv H; Lu G; Zhang Q; Yang Y; Zhou J
    Am J Physiol Cell Physiol; 2022 May; 322(5):C814-C824. PubMed ID: 35319902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorating cancer cachexia by inhibiting cancer cell release of Hsp70 and Hsp90 with omeprazole.
    Liu Z; Xiong J; Gao S; Zhu MX; Sun K; Li M; Zhang G; Li YP
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):636-647. PubMed ID: 34729960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Handelin alleviates cachexia- and aging-induced skeletal muscle atrophy by improving protein homeostasis and inhibiting inflammation.
    Zhang HJ; Wang BH; Wang X; Huang CP; Xu SM; Wang JL; Huang TE; Xiao WL; Tian XL; Lan XQ; Wang QQ; Xiang Y
    J Cachexia Sarcopenia Muscle; 2024 Feb; 15(1):173-188. PubMed ID: 38009816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C/EBPβ promotes the expression of atrophy-inducing factors by tumours and is a central regulator of cancer cachexia.
    AlSudais H; Rajgara R; Saleh A; Wiper-Bergeron N
    J Cachexia Sarcopenia Muscle; 2022 Feb; 13(1):743-757. PubMed ID: 35014202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Alcohol Consumption Enhances Skeletal Muscle Wasting in Mice Bearing Cachectic Cancers: The Role of TNFα/Myostatin Axis.
    Li Y; Zhang F; Modrak S; Little A; Zhang H
    Alcohol Clin Exp Res; 2020 Jan; 44(1):66-77. PubMed ID: 31657476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified Sijunzi decoction can alleviate cisplatin-induced toxicity and prolong the survival time of cachectic mice by recovering muscle atrophy.
    Chen JM; Yang TT; Cheng TS; Hsiao TF; Chang PM; Leu JY; Wang FS; Hsu SL; Huang CF; Lai JM
    J Ethnopharmacol; 2019 Apr; 233():47-55. PubMed ID: 30590199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice.
    Brown JL; Lee DE; Rosa-Caldwell ME; Brown LA; Perry RA; Haynie WS; Huseman K; Sataranatarajan K; Van Remmen H; Washington TA; Wiggs MP; Greene NP
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):987-1002. PubMed ID: 30328290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice.
    Murphy KT; Chee A; Gleeson BG; Naim T; Swiderski K; Koopman R; Lynch GS
    Am J Physiol Regul Integr Comp Physiol; 2011 Sep; 301(3):R716-26. PubMed ID: 21677277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin S activity controls chronic stress-induced muscle atrophy and dysfunction in mice.
    Wan Y; Piao L; Xu S; Meng X; Huang Z; Inoue A; Wang H; Yue X; Jin X; Nan Y; Shi GP; Murohara T; Umegaki H; Kuzuya M; Cheng XW
    Cell Mol Life Sci; 2023 Aug; 80(9):254. PubMed ID: 37589754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.